Crinetics Pharmaceuticals CRNX
CRNX
$84.95 +0.00 (+0.00%)
At close: Sep 2, 2026 · 4:00 PM EDT

Crinetics Pharmaceuticals (CRNX) Return on Capital Employed [ROCE] (2018 - 2026)

Updated

Crinetics Pharmaceuticals (CRNX) reported Return on Capital Employed [ROCE] of -42.84% for Q2 2026, down 9.19 percentage points from -33.65% a year earlier but up 2.92 percentage points from the prior quarter.

Analysis

Crinetics Pharmaceuticals (CRNX) Return on Capital Employed [ROCE] (2018 - 2026) Analysis & Trends

For FY2025, Crinetics Pharmaceuticals posted Return on Capital Employed [ROCE] of -43.23%, down 8.49 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has a five-year change of +7.96 percentage points (FY2020 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -34.74% in FY2024 (+14.74 pp), -49.49% in FY2023 (+2.35 pp), -51.84% in FY2022 (-8.97 pp) and -42.87% in FY2021 (+8.32 pp).
  • Five-year quarterly Return on Capital Employed [ROCE] spans a low of -70.84% in Q2 2023 and a high of -28.10% in Q1 2025.
  • Year over year, Return on Capital Employed [ROCE] has now declined in each of the last five quarters, with an average year-over-year change of -3.47 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q2 2024 (a gain of 40.04 percentage points); the low point was Q2 2023 (a drop of 32.26 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -45.76% (Q1 2026), -48.02% (Q4 2025) and -40.89% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Crinetics Pharmaceuticals 8.99 Bn 8.99 Bn 24.96 Mn -42.84%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -42.84%
Mar 31, 2026 -45.76%
Dec 31, 2025 -48.02%
Sep 30, 2025 -40.89%
Jun 30, 2025 -33.65%
Mar 31, 2025 -28.10%
Dec 31, 2024 -30.09%
Sep 30, 2024 -34.75%
Jun 30, 2024 -30.80%
Mar 31, 2024 -32.87%
Dec 31, 2023 -37.44%
Sep 30, 2023 -48.60%
Jun 30, 2023 -70.84%
Mar 31, 2023 -59.34%
Dec 31, 2022 -49.26%
Sep 30, 2022 -39.92%
Jun 30, 2022 -38.58%
Mar 31, 2022 -36.85%
Dec 31, 2021 -40.77%
Sep 30, 2021 -49.13%
API Access

Crinetics Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CRNX&period=max&api_key=YOUR_API_KEY